Acute Coronary Syndrome
Conditions
Brief summary
The study is aimed to optimized the dose-adjusted regimen of beta-blockers in patients with acute coronary syndrome by investigating therapeutic and curative results of target doses Beta-blockers using the dose-adjusted pathway of beta-blockers.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Age ≥ 18 years * Patients diagnosed as acute coronary syndromes including acute ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevated acute coronary syndrome (NSTE-ACS) * Patients or whose legal representatives signed written informed consent form
Exclusion criteria
Patients should been excluded if they meet any of the following
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Major adverse cardiovascular and cerebrovascular events (MACCE) | Within 1 year after surgery | MACCE were defined as a composite of all-cause death, myocardial infarction (MI), unplanned target vessel revascularization (TVR), stent thrombosis (ST) and stroke. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Resting heart rate | Within 1 year after surgery | The resting heart rate of the body is the number of contractions of the heart that occur in a single minute while the body is at complete rest. |
| Blood pressure (systolic & diastolic) | Within 1 year after surgery | Blood pressure (BP) is the pressure of circulating blood on the walls of blood vessels. |
| Ejection fraction | Within 1 year after surgery | Ejection fraction (EF) is the volumetric fraction of fluid (usually blood) ejected from a chamber (usually the heart) with each contraction (or heartbeat). |
| Serum norepinephrine | Within 1 year after surgery | Norepinephrine is a neurotransmitter that is secreted in response to stress. |
Countries
China